Antimicrobial use in hospitals remains high in 2023.
Understanding trends in antimicrobial use helps optimize stewardship efforts. In 2023, 49.7% of inpatients received antimicrobials, with decreased fluoroquinolone and increased cephalosporin use. The study highlights shifts in antimicrobial prescribing patterns, crucial for stewardship programs. Antimicrobial use remains high, with notable shifts in drug classes.
Authors: Keino BC, Eure T, Ramirez RA, Nadle J, Lee JE, Lehmann M, Sardenga L, Czaja CA, Johnston H, Kellogg M, Emanuel C, Cilwick A, Correa MA, Maloney M, Prignano J, Ray SM, Howard-Anderson J, Carswell S, Wilson LE, Perlmutter R, Mahoehney JP, Lynfield R, Sievers M, Cline C, Judson M, Dumyati G, Hurley C, Keller E, Walsh M, Licherdell E, Tellerman J, Pierce R, Ocampo VLS, Samper ME, Hires KA, Adrian LT, Tammer RP, Zhang AY, Hiratzka S, Dusko A, Wilson C, Harriott M, Li R, Neuhauser MM, Thompson ND, Magill SS, Grigg CT, Chea N
Citation: Keino BC, Eure T, Ramirez RA, et al. Antimicrobial Use in U.S. Hospitals: Comparison of 2015 and 2023 Prevalence Surveys. Open forum infectious diseases. 2026;13(8):ofag450. doi:10.1093/ofid/ofag450
Article Links: PubMed · Journal / DOI · Free Full Text (PMC)
The full analysis for this article is being written and reviewed. Every analysis is checked by a licensed pharmacist before it publishes.